Lymphedema treatment market size is worth $11.58 billion per


New York, June 08, 2022 (GLOBE NEWSWIRE) — The Insight Partners has released the latest research study on “Lymphedema Treatment Market Size and Forecast to 2028 – Impact of COVID-19 and Global Analysis – by Condition Type, Treatment Type, End User and Geography”, the growing prevalence of lymphedema cases and the growing number of healthcare facilities and Lymphedema management programs are fueling the overall market growth.

The sample pages show the content structure and nature of the information included in this research study which presents a qualitative and quantitative analysis:

Report cover Details
Market size Value in US$8.15 billion in 2021
Market Size Value by $11.58 billion by 2028
Rate of growth CAGR of 5.1% from 2021 to 2028
Forecast period 2021-2028
base year 2021
Number of pages 209
Number of tables 138
Number of graphs and figures 71
Historical data available Yes
Segments Covered Condition type, treatment type and end user
Regional scope North America; Europe; Asia Pacific; Latin America; AEM
Country scope United States, United Kingdom, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends

Lymphedema Treatment Market Analysis: Competitive Landscape and Key Developments

BIOCOMPRESSION SYSTEMS, Tactile Medical, Smith and Nephew, BSN Medical GmbH, Lohmann & Rauscher GmbH & Co. KG, SIGVARIS GROUP, ThermoTek, Huntleigh Healthcare Limited, 3M, Mego Afek Ltd. are among the leading companies operating in the lymphedema treatment market. Market leaders focus on new product launches, expansion and diversification, as well as acquisition strategies, which allow them to exploit existing business opportunities.

Schedule a pre-sale discussion with the team of authors in a niche you prefer to answer questions about study scope, customization, introduction to research methodology, technology assistance and market definitions: /TIPRE00026594/

In September 2018, SIGVARIS Group launched an innovative garment, SECURE, with graduated compression and containment properties for the management of advanced venous edema, lymphedema, post-surgical edema and general edema.

In April 2017, Esity announced the acquisition of BSN Medical, a pioneer in providing medical solutions and developing products for wound care, compression therapy and orthopaedics.

Lymphedema Treatment Market: Segmental Overview

Based on disease type, the lymphedema treatment market is segmented into primary lymphedema and secondary lymphedema. The secondary lymphedema segment is expected to account for a larger market share between 2021 and 2028. Rising cases of disruption of lymphatic systems due to trauma are leading to more secondary lymphedema cases. In the United States as well as other countries, cancer treatment damages the lymphatic system, thereby driving the growth of the lymphedema market.

By type of treatment, the lymphedema treatment market is segmented into laser therapy, compression devices and bandages, drug therapy, physiological procedures, reduction procedures and others. The physiological procedures segment market is further segmented into lympho-venous anastomosis (LVA) and vascularized lymph node transfer (VLNT). The massive reduction procedures segment market is sub-segmented into surgical reduction, liposuction and others.

Get lucrative discounts on our latest research reports. We offer student, business and special periodical discounts to our customers. Please complete the form for DISCOUNTED PRICE @

Continuous advancements in lymphedema management are contributing to the overall market growth. According to the report published in the Journal of Skin and Sexually Transmitted Diseases (JSSTD), there has been a paradigm shift in the lymphedema case management model, with an increased emphasis on the physiology of the lymphatic system and the exploitation of advances in super-microsurgery techniques. Advances in the management of lymphedema mainly focus on an in-depth understanding of the microscopic anatomy of lymphatic vessels and various arrangements for alternative physiological pathways redirecting lymphatic flow to prevent secondary tissue changes. On the other hand, due to recent developments, the surgical management of lymphedema has gained popularity all over the world. For example, the JSSTD report indicates that the complete success of surgical management of lymphedema depends on the severity of the disease. For example, with a keen interest in the early management of post-mastectomy lymphedema over the past decade, physician attention is shifting to physiological surgical procedures to facilitate lymphatic drainage. Additionally, advances such as ICG lymphangiography and micro-lymphatic surgery indicate promising results in the early stages of the disease. Thus, ongoing research in tissue engineering, lymphangiogenic vascular endothelial growth factor therapy, and immunomodulatory therapy are likely to uncover better alternatives for the management of lymphedema in the years to come.

The increasing incidence of breast cancer-related lymphedema (BCRL) further increases the demand for lymphedema treatment. BCRL is a form of secondary lymphedema occurring after axillary surgery or radiation therapy, evaluating 14-54% of breast cancer survivors. A report from the General Hospital Corporation states that although there is no cure for BCRL, treatment can help minimize patient burden. Additionally, the treatment received by most patients focuses on physical therapy rather than medication. In addition, compression devices and bandages show a substantial effect in reducing the prevalence of BCRL and prove to be an essential treatment to prevent infection in combination with all concomitant treatments.

Immediate delivery of our ready-to-use reports and the latest research studies, thanks to flexible and convenient payment methods:

Cycle through adjacent reports:

Lymphedema Diagnostics Market Forecast to 2028 – Impact of Covid-19 and Global Analysis – By Technology (Magnetic Resonance Imaging, Ultrasound Imaging, Lymphoscintigraphy, CT Scan, X-ray Lymphography, Bioimpedance Analysis, Fluorescence Imaging in the near infrared); Indication (Cancer, Inflammatory Diseases, Cardiovascular Diseases, Others); End user (hospitals, diagnostic centers, research institutes and universities) and geography

Compression Therapy Devices Market Forecast to 2028 – Impact of COVID-19 and Global Analysis by Treatment Type (Static Compression Therapy, Dynamic Compression Therapy); Application (treatment of varicose veins, treatment of deep vein thrombosis, treatment of lymphedema, treatment of leg ulcers, others); End user (hospitals, ambulatory surgery centers, others)

Compression Socks Market Forecast to 2028 – Impact of COVID-19 and Global Analysis by Product (Knee Compression Stockings, Thigh Compression Stockings, Pantyhose Compression Stockings); Indication (venous disorders, lymphoedema, sports-related injuries, others); Distribution channel (online shops, pharmacies and hospital clinics, retail stores) and geography

Home Sequential Compression Devices Market Forecast to 2028 – Impact of COVID-19 and Global Analysis by Device Type (Alternative Sequential Compression Device (ASCD), Simultaneous Sequential Compression Device (SSCD)); Type (Standard, PORTABLE); Application (deep vein thrombosis, lymphedema management, chronic venous insufficiency (CVI), others) and geography

Laser Therapy Market Forecast to 2027 – Impact of Covid-19 and Global Analysis by Type (Solid, Liquid, Gas and Diode); Application (dermatology and aesthetics, dental, ophthalmology, urology, cardiovascular, oncology and other applications); End user (specialty clinics, hospitals, outpatient clinics and others) and geography

Radial Compression Devices Market Forecast to 2028 – Impact of Covid-19 and Global Analysis – By Product (B&/Strap-based Radial Compression Devices, Knob Radial Compression Devices, Plate Radial Compression Devices ); Use (disposable, reusable); Application (Diagnosis, Surgical Intervention); End user (hospitals and specialized centers, outpatient centers, others)

About Us:
The Insight Partners is an industry unique research provider of actionable intelligence. We help our clients find solutions to their research needs through our syndicated research and advisory services. We specialize in industries such as Semiconductors and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Health IT, Manufacturing and Construction, Medical Devices , technology, media and telecommunications, chemicals and materials.

Contact us:
If you have any questions about this report or would like further information, please contact us:

Contact person: Sameer Joshi
Email: [email protected]
Phone: +1-646-491-9876

Press release:


About Author

Comments are closed.